118 related articles for article (PubMed ID: 25526901)
1. Optimal contouring of seminal vesicle for definitive radiotherapy of localized prostate cancer: comparison between EORTC prostate cancer radiotherapy guideline, RTOG0815 protocol and actual anatomy.
Qi X; Gao XS; Asaumi J; Zhang M; Li HZ; Ma MW; Zhao B; Li FY; Wang D
Radiat Oncol; 2014 Dec; 9():288. PubMed ID: 25526901
[TBL] [Abstract][Full Text] [Related]
2. [Changes in target volumes definition by using MRI for prostate bed radiotherapy planning--preliminary results].
Sefrová J; Paluska ; Odrázka K; Belobradek Z; Hoffmann P; Prosvic P; Brod'ák M; Louda M; Macingová Z; Vosmik M
Klin Onkol; 2010; 23(4):256-63. PubMed ID: 20806824
[TBL] [Abstract][Full Text] [Related]
3. Treatment of prostate cancer with radiotherapy: should the entire seminal vesicles be included in the clinical target volume?
Kestin L; Goldstein N; Vicini F; Yan D; Korman H; Martinez A
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):686-97. PubMed ID: 12377319
[TBL] [Abstract][Full Text] [Related]
4. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio.
Hille A; Töws N; Schmidberger H; Hess CF
Strahlenther Onkol; 2005 Dec; 181(12):789-95. PubMed ID: 16362789
[TBL] [Abstract][Full Text] [Related]
5. [Quantification of the volumetric benefit of image-guided radiotherapy (IGRT) in prostate cancer: margins and presence probability map].
Cazoulat G; de Crevoisier R; Simon A; Louvel G; Manens JP; Lafond C; Haigron P
Cancer Radiother; 2009 Sep; 13(5):365-74. PubMed ID: 19643650
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric impact of interfraction prostate and seminal vesicle volume changes and rotation: A post-hoc analysis of a phase III randomized trial of MRI-guided versus CT-guided stereotactic body radiotherapy.
Ma TM; Neylon J; Casado M; Sharma S; Sheng K; Low D; Yang Y; Steinberg ML; Lamb J; Cao M; Kishan AU
Radiother Oncol; 2022 Feb; 167():203-210. PubMed ID: 34979212
[TBL] [Abstract][Full Text] [Related]
7. [Choice of optimal margins in prostate conformal radiotherapy].
Khalifa J; Commandeur F; Bachaud JM; de Crevoisier R
Cancer Radiother; 2013 Oct; 17(5-6):461-9. PubMed ID: 23973458
[TBL] [Abstract][Full Text] [Related]
8. The relationship between the bladder volume and optimal treatment planning in definitive radiotherapy for localized prostate cancer.
Nakamura N; Shikama N; Takahashi O; Sekiguchi K; Hama Y; Akahane K; Nakagawa K
Acta Oncol; 2012 Jul; 51(6):730-4. PubMed ID: 22132747
[TBL] [Abstract][Full Text] [Related]
9. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.
Peeters ST; Heemsbergen WD; van Putten WL; Slot A; Tabak H; Mens JW; Lebesque JV; Koper PC
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1019-34. PubMed ID: 15752881
[TBL] [Abstract][Full Text] [Related]
10. ESTRO ACROP consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer.
Salembier C; Villeirs G; De Bari B; Hoskin P; Pieters BR; Van Vulpen M; Khoo V; Henry A; Bossi A; De Meerleer G; Fonteyne V
Radiother Oncol; 2018 Apr; 127(1):49-61. PubMed ID: 29496279
[TBL] [Abstract][Full Text] [Related]
11. Definition of the CTV prostate in CT and MRI by using CT-MRI image fusion in IMRT planning for prostate cancer.
Hentschel B; Oehler W; Strauss D; Ulrich A; Malich A
Strahlenther Onkol; 2011 Mar; 187(3):183-90. PubMed ID: 21347638
[TBL] [Abstract][Full Text] [Related]
12. Postoperative radiotherapy in prostate cancer: the case of the missing target.
Croke J; Malone S; Roustan Delatour N; Belanger E; Avruch L; Morash C; Kayser C; Underhill K; Spaans J
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1160-8. PubMed ID: 22270169
[TBL] [Abstract][Full Text] [Related]
13. Treatment simulations with a statistical deformable motion model to evaluate margins for multiple targets in radiotherapy for high-risk prostate cancer.
Thörnqvist S; Hysing LB; Zolnay AG; Söhn M; Hoogeman MS; Muren LP; Bentzen L; Heijmen BJ
Radiother Oncol; 2013 Dec; 109(3):344-9. PubMed ID: 24183863
[TBL] [Abstract][Full Text] [Related]
14. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.
Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189
[TBL] [Abstract][Full Text] [Related]
15. Quantification of prostate and seminal vesicle interfraction variation during IMRT.
Frank SJ; Dong L; Kudchadker RJ; De Crevoisier R; Lee AK; Cheung R; Choi S; O'Daniel J; Tucker SL; Wang H; Kuban DA
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):813-20. PubMed ID: 18207664
[TBL] [Abstract][Full Text] [Related]
16. Distal seminal vesicle invasion by prostate adenocarcinoma does not occur in isolation of proximal seminal vesicle invasion or lymphovascular infiltration.
Samaratunga H; Samaratunga D; Perry-Keene J; Adamson M; Yaxley J; Delahunt B
Pathology; 2010 Jun; 42(4):330-3. PubMed ID: 20438404
[TBL] [Abstract][Full Text] [Related]
17. Quality assurance of the 22961 EORTC trial. A phase III study of the optimal combination of hormonal adjuvant treatment by LHRH analogue and radiation therapy for the management of locally advanced prostate cancer: the dummy run.
Kouloulias VE; Giraud JY; Davis BJ; Dusserre A; Zurlo A; Bolla M
Radiother Oncol; 2004 Oct; 73(1):11-20. PubMed ID: 15465141
[TBL] [Abstract][Full Text] [Related]
18. Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU).
Sargos P; Guerif S; Latorzeff I; Hennequin C; Pommier P; Lagrange JL; Créhange G; Chapet O; de Crevoisier R; Azria D; Supiot S; Habibian M; Soulié M; Richaud P
Cancer Treat Rev; 2015 Dec; 41(10):814-20. PubMed ID: 26508669
[TBL] [Abstract][Full Text] [Related]
19. Automatic segmentation of pelvic structures from magnetic resonance images for prostate cancer radiotherapy.
Pasquier D; Lacornerie T; Vermandel M; Rousseau J; Lartigau E; Betrouni N
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):592-600. PubMed ID: 17498571
[TBL] [Abstract][Full Text] [Related]
20. Proposal of a post-prostatectomy clinical target volume based on pre-operative MRI: volumetric and dosimetric comparison to the RTOG guidelines.
Croke J; Maclean J; Nyiri B; Li Y; Malone K; Avruch L; Kayser C; Malone S
Radiat Oncol; 2014 Dec; 9():303. PubMed ID: 25534278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
